CEO Joe Payne told investors at the 38th Annual ROTH Conference that the company is refocusing on rare disease programs after ...
Two scientists who worked on the science behind the COVID-19 vaccine earned the prestigious 2023 Nobel Prize in Physiology or Medicine. Katalin Karikó and Dr. Drew Weissman, both University of ...
Since the COVID-19 pandemic, mRNA vaccines have gained attention as a next-generation pharmaceutical technology. mRNA ...
WASHINGTON, DC: Jayanta Bhattacharya, Director of the National Institutes of Health. (Photo by Andrew Harnik/Getty Images) Director of the National Institutes of Health, Jay Bhattacharya, recently ...
STONY BROOK, NY / ACCESSWIRE / July 13, 2023 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that it has acquired ...
Initiate Moderna with a Hold rating at a $25 target price (lower than the current price), citing balanced risk-reward despite the advanced mRNA platform and robust pipeline. MRNA's near-term execution ...
The administration had cut crucial funding for mRNA-based therapies. The rest of the world might step in and benefit.
The same groundbreaking technology that enabled rapid COVID-19 vaccine development is now poised to revolutionize medicine in ways that seemed impossible just a few years ago. Messenger RNA vaccines ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results